tiprankstipranks
Advertisement
Advertisement
Lupin Wins Tentative U.S. FDA Nod for Generic Pitolisant Tablets
PremiumCompany AnnouncementsLupin Wins Tentative U.S. FDA Nod for Generic Pitolisant Tablets
1M ago
Lupin Receives Two FDA Observations After Ankleshwar Plant Inspection
Premium
Company Announcements
Lupin Receives Two FDA Observations After Ankleshwar Plant Inspection
2M ago
Lupin Says GST Department Inspection Concludes With No Financial Impact
Premium
Company Announcements
Lupin Says GST Department Inspection Concludes With No Financial Impact
2M ago
Lupin Strikes Global Semaglutide Deal With Galenicum Across 23 Markets
PremiumCompany AnnouncementsLupin Strikes Global Semaglutide Deal With Galenicum Across 23 Markets
3M ago
Lupin and PolyPeptide Forge Alliance to Boost Global Peptide Supply Chain
Premium
Company Announcements
Lupin and PolyPeptide Forge Alliance to Boost Global Peptide Supply Chain
5M ago
Lupin Limited Gains U.S. FDA Approval for First Biosimilar, Armlupeg
Premium
Company Announcements
Lupin Limited Gains U.S. FDA Approval for First Biosimilar, Armlupeg
5M ago
Lupin Limited’s PEGASUS Study: A New Horizon in Pediatric Myotonic Disorder Treatment
PremiumCompany AnnouncementsLupin Limited’s PEGASUS Study: A New Horizon in Pediatric Myotonic Disorder Treatment
6M ago
Lupin Limited’s ACHILLES Study: A New Horizon in Myotonia Treatment
Premium
Company Announcements
Lupin Limited’s ACHILLES Study: A New Horizon in Myotonia Treatment
6M ago
Lupin Limited’s Phase 3 Study on Mexiletine PR: A Potential Game-Changer for Myotonic Dystrophy
Premium
Company Announcements
Lupin Limited’s Phase 3 Study on Mexiletine PR: A Potential Game-Changer for Myotonic Dystrophy
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100